1. Home
  2. ALGN vs TEM Comparison

ALGN vs TEM Comparison

Compare ALGN & TEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALGN
  • TEM
  • Stock Information
  • Founded
  • ALGN 1997
  • TEM 2015
  • Country
  • ALGN United States
  • TEM United States
  • Employees
  • ALGN N/A
  • TEM N/A
  • Industry
  • ALGN Industrial Specialties
  • TEM
  • Sector
  • ALGN Health Care
  • TEM
  • Exchange
  • ALGN Nasdaq
  • TEM NYSE
  • Market Cap
  • ALGN 12.5B
  • TEM 11.9B
  • IPO Year
  • ALGN N/A
  • TEM 2024
  • Fundamental
  • Price
  • ALGN $205.56
  • TEM $64.49
  • Analyst Decision
  • ALGN Buy
  • TEM Buy
  • Analyst Count
  • ALGN 13
  • TEM 12
  • Target Price
  • ALGN $239.33
  • TEM $65.09
  • AVG Volume (30 Days)
  • ALGN 852.4K
  • TEM 9.3M
  • Earning Date
  • ALGN 07-30-2025
  • TEM 08-08-2025
  • Dividend Yield
  • ALGN N/A
  • TEM N/A
  • EPS Growth
  • ALGN N/A
  • TEM N/A
  • EPS
  • ALGN 5.50
  • TEM N/A
  • Revenue
  • ALGN $3,980,843,000.00
  • TEM $803,315,000.00
  • Revenue This Year
  • ALGN $5.73
  • TEM $81.43
  • Revenue Next Year
  • ALGN $5.63
  • TEM $24.80
  • P/E Ratio
  • ALGN $37.29
  • TEM N/A
  • Revenue Growth
  • ALGN 1.64
  • TEM 42.93
  • 52 Week Low
  • ALGN $141.74
  • TEM $31.36
  • 52 Week High
  • ALGN $262.87
  • TEM $91.45
  • Technical
  • Relative Strength Index (RSI)
  • ALGN 64.00
  • TEM N/A
  • Support Level
  • ALGN $188.00
  • TEM N/A
  • Resistance Level
  • ALGN $205.30
  • TEM N/A
  • Average True Range (ATR)
  • ALGN 5.88
  • TEM 0.00
  • MACD
  • ALGN 0.45
  • TEM 0.00
  • Stochastic Oscillator
  • ALGN 97.43
  • TEM 0.00

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

About TEM TEMPUS AI INC

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Share on Social Networks: